MedTrace Logo

TBE Zone 2 PMS in Japan

NCT07049913 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2026-02-05

No results posted yet for this study

Summary

The goal of this surveillance is to confirm the TBE device's safety and efficacy in patients treated with proximal landing in Zone 2 in the post-marketing period.

Conditions

  • Aneurysm Thoracic
  • Dissection of Aorta, Thoracic
  • Trauma

Interventions

DEVICE

Gore® TAG® Thoracic Aortic Branch Stent Graft System

Patients who attempted implant of TBE in Zone 2 during the enrollment period of this surveillance.

Sponsors & Collaborators

  • CMIC Co, Ltd. Japan

    collaborator INDUSTRY

  • W.L.Gore & Associates

    lead INDUSTRY

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-12-15
Primary Completion
2034-02-28
Completion
2034-02-28
FDA Device
Yes

Countries

  • Japan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07049913 on ClinicalTrials.gov